Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fernandez

Showing results (1401-1410 of 1,725) with videos related to

Pageof 173
Sort By:
Gut|November 19, 2020
Sphingomyelin synthase 1 mediates hepatocyte pyroptosis to trigger non-alcoholic steatohepatitisEun Hee Koh, Ji Eun Yoon, Myoung Seok Ko, et al.
Neurosurgery|April 21, 2026
Standardized Perioperative Protocols Are Associated With Reduced Length of Stay and Readmission in Cushing Disease: Results From the Multicenter RAPID StudyCarter M Suryadevara, Jorge E Salcedo-Sifuentes, Andrew S Little, et al.
JAMA Otolaryngology-- Head & Neck Surgery|October 30, 2025
Proton Beam vs Intensity-Modulated Radiotherapy in Olfactory NeuroblastomaAnthony Tang, Samuel Adida, Jack Donohue, et al.
Communications Biology|January 13, 2021
Pharmacological inactivation of the prion protein by targeting a folding intermediateGiovanni Spagnolli, Tania Massignan, Andrea Astolfi, et al.
Neurosurgery|July 15, 2024
Multicenter Registry of Adenomas of the Pituitary and Related Disorders: Initial Description of Cushing Disease Cohort, Surgical Outcomes, and Surgeon CharacteristicsAndrew S Little, Michael Karsy, James J Evans, et al.
The Pharmacogenomics Journal|February 8, 2012
Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administrationC Fernandez-Rozadilla, J B Cazier, V Moreno, et al.
Leukemia|February 29, 2020
miR-146a rs2431697 identifies myeloproliferative neoplasm patients with higher secondary myelofibrosis progression riskF Ferrer-Marín, A B Arroyo, B Bellosillo, et al.
Annals of Neurology|July 26, 2024
Diagnostic MRI Score to Differentiate Susac Syndrome from Primary Angiitis of the Central Nervous System and Multiple SclerosisMariano Marrodan, Ismael L Calandri, Diana I Bocancea, et al.
Nature Reviews. Gastroenterology & Hepatology|June 7, 2024
Designing clinical trials to address alcohol use and alcohol-associated liver disease: an expert panel Consensus StatementBrian P Lee, Katie Witkiewitz, Jessica Mellinger, et al.
Alcoholism, Clinical and Experimental Research|June 8, 2001
How is the liver primed or sensitized for alcoholic liver disease?H Tsukamoto, Y Takei, C J McClain, et al.
Pageof 173

Showing results (1401-1410 of 1,725) with videos related to

Sort By:
Pageof 173
Gut|November 19, 2020
Sphingomyelin synthase 1 mediates hepatocyte pyroptosis to trigger non-alcoholic steatohepatitisEun Hee Koh, Ji Eun Yoon, Myoung Seok Ko, et al.
Neurosurgery|April 21, 2026
Standardized Perioperative Protocols Are Associated With Reduced Length of Stay and Readmission in Cushing Disease: Results From the Multicenter RAPID StudyCarter M Suryadevara, Jorge E Salcedo-Sifuentes, Andrew S Little, et al.
JAMA Otolaryngology-- Head & Neck Surgery|October 30, 2025
Proton Beam vs Intensity-Modulated Radiotherapy in Olfactory NeuroblastomaAnthony Tang, Samuel Adida, Jack Donohue, et al.
Communications Biology|January 13, 2021
Pharmacological inactivation of the prion protein by targeting a folding intermediateGiovanni Spagnolli, Tania Massignan, Andrea Astolfi, et al.
Neurosurgery|July 15, 2024
Multicenter Registry of Adenomas of the Pituitary and Related Disorders: Initial Description of Cushing Disease Cohort, Surgical Outcomes, and Surgeon CharacteristicsAndrew S Little, Michael Karsy, James J Evans, et al.
The Pharmacogenomics Journal|February 8, 2012
Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administrationC Fernandez-Rozadilla, J B Cazier, V Moreno, et al.
Leukemia|February 29, 2020
miR-146a rs2431697 identifies myeloproliferative neoplasm patients with higher secondary myelofibrosis progression riskF Ferrer-Marín, A B Arroyo, B Bellosillo, et al.
Annals of Neurology|July 26, 2024
Diagnostic MRI Score to Differentiate Susac Syndrome from Primary Angiitis of the Central Nervous System and Multiple SclerosisMariano Marrodan, Ismael L Calandri, Diana I Bocancea, et al.
Nature Reviews. Gastroenterology & Hepatology|June 7, 2024
Designing clinical trials to address alcohol use and alcohol-associated liver disease: an expert panel Consensus StatementBrian P Lee, Katie Witkiewitz, Jessica Mellinger, et al.
Alcoholism, Clinical and Experimental Research|June 8, 2001
How is the liver primed or sensitized for alcoholic liver disease?H Tsukamoto, Y Takei, C J McClain, et al.
Pageof 173